Clinical Trials Directory

Trials / Completed

CompletedNCT00805506

Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
HealthPartners Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluate the usefulness of continuous glucose monitoring devices in terms of their ability to identify periods throughout the day when glucose varies significantly.

Detailed description

Many CGM systems use a surrogate for blood glucose--tissue glucose or interstitial glucose. Interstitial fluid (ISF) is the medium for these approaches. A physiological lag in ISF glucose relative to capillary blood glucose has been noted, probably due to relatively low blood perfusion at the sampling site. 9 This physiological lag can result in an accuracy error, manifesting as a significant bias between blood and tissue glucose, particularly during periods of rapid glucose change. This lag error might be particularly meaningful when glucose is rapidly dropping towards hypoglycemia.

Conditions

Timeline

Start date
2006-02-01
Primary completion
2007-04-01
Completion
2007-04-01
First posted
2008-12-09
Last updated
2015-11-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00805506. Inclusion in this directory is not an endorsement.